WrapManager Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,367
Closed -$660K 299
2020
Q4
$660K Buy
1,367
+38
+3% +$20.5K 0.19% 120
2020
Q3
$744K Buy
1,329
+131
+11% +$79.4K 0.25% 93
2020
Q2
$747K Sell
1,198
-4
-0.3% -$2.27K 0.28% 92
2020
Q1
$587K Buy
1,202
+160
+15% +$66K 0.26% 100
2019
Q4
$391K Sell
1,042
-159
-13% -$53.5K 0.12% 181
2019
Q3
$333K Sell
1,201
-28
-2% -$8.29K 0.11% 202
2019
Q2
$385K Sell
1,229
-116
-9% -$38.6K 0.12% 178
2019
Q1
$552K Sell
1,345
-113
-8% -$46.5K 0.18% 137
2018
Q4
$545K Sell
1,458
-97
-6% -$35.5K 0.19% 135
2018
Q3
$628K Buy
1,555
+115
+8% +$43.8K 0.2% 128
2018
Q2
$497K Buy
1,440
+130
+10% +$40.7K 0.17% 158
2018
Q1
$451K Buy
1,310
+82
+7% +$28.5K 0.15% 147
2017
Q4
$462K Sell
1,228
-56
-4% -$22.7K 0.15% 148
2017
Q3
$574K Sell
1,284
-183
-12% -$87.1K 0.19% 113
2017
Q2
$721K Buy
1,467
+127
+9% +$55.6K 0.25% 91
2017
Q1
$519K Buy
1,340
+274
+26% +$102K 0.19% 108
2016
Q4
$391K Buy
1,066
+223
+26% +$84.8K 0.15% 135
2016
Q3
$339K Buy
843
+206
+32% +$82.6K 0.13% 141
2016
Q2
$222K Buy
+637
New +$245K 0.09% 196

Other funds holding REGN

WrapManager Inc's REGN Position: Q1 2021 in Review

WrapManager Inc sold out of Regeneron Pharmaceuticals (REGN) in Q1 2021, closing a stake of 1,367 shares — an estimated $660K sold.

WrapManager Inc first reported a position in REGN in Q2 2016 and held it in 19 quarters. The position peaked at $747K in Q2 2020. 924 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

  • WrapManager Inc reported no remaining Regeneron Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • WrapManager Inc sold 1,367 Regeneron Pharmaceuticals shares in Q1 2021, an estimated $660K.
  • WrapManager Inc first reported a position in Regeneron Pharmaceuticals in Q2 2016 and held it in 19 quarters.
  • WrapManager Inc's Regeneron Pharmaceuticals position peaked at $747K in Q2 2020.
  • 924 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on WrapManager Inc's 13F filing for Q1 2021, filed 10 May 2021.